Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Concentra Group Holdings Parent, Inc.CON · Entity 4001 | Director | August 21, 2026 | September 01, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Concentra Group Holdings Parent, Inc.
Report date August 21, 2026 · Filed September 01, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,663,794 |
Reported balance
After 2026-08-21 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2026-08-21 · Disposition to issuer · Disposed 770,000 · Balance 4,663,794 F1: The shares were sold to the Issuer pursuant to a Stock Repurchase Agreement, dated August 21, 2026, between the Reporting Person (and certain trusts for the benefit of the Reporting Person's descendants) and the Issuer (the "Stock Repurchase Agreement"). Under the Stock Repurchase Agreement, the Issuer agreed to purchase an aggregate of 1,000,000 shares of common stock at a price of $34.65 per share. The Reporting Person sold 770,000 shares held directly and 230,000 shares held indirectly through trusts of which the Reporting Person is the trustee. F2: The dispositions reported herein were approved in advance by the Audit Committee of the Issuer's Board of Directors, which consists solely of two or more Non-Employee Directors (as defined in Rule 16b-3), for purposes of exempting the transactions from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(e) thereunder. F3: The total number of securities reported has been updated to correct an administrative error. |
| Common StockSEC Table I · non-derivative | IndirectBy the Robert A. Ortenzio Descendants Trust | 882,115 |
Reported balance
After 2026-08-21 transaction · row 2
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 2 · 2026-08-21 · Disposition to issuer · Disposed 150,000 · Balance 882,115 F1: The shares were sold to the Issuer pursuant to a Stock Repurchase Agreement, dated August 21, 2026, between the Reporting Person (and certain trusts for the benefit of the Reporting Person's descendants) and the Issuer (the "Stock Repurchase Agreement"). Under the Stock Repurchase Agreement, the Issuer agreed to purchase an aggregate of 1,000,000 shares of common stock at a price of $34.65 per share. The Reporting Person sold 770,000 shares held directly and 230,000 shares held indirectly through trusts of which the Reporting Person is the trustee. F2: The dispositions reported herein were approved in advance by the Audit Committee of the Issuer's Board of Directors, which consists solely of two or more Non-Employee Directors (as defined in Rule 16b-3), for purposes of exempting the transactions from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(e) thereunder. F4: 150,000 shares were sold from The Robert A. Ortenzio Descendants Trust at $34.65 per share for aggregate proceeds of $5,197,500. The Reporting Person is the trustee of this trust and may be deemed to have voting and investment power over the shares held therein. |
| Common StockSEC Table I · non-derivative | IndirectBy the Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio | 196,286 |
Reported balance
After 2026-08-21 transaction · row 3
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 3 · 2026-08-21 · Disposition to issuer · Disposed 30,000 · Balance 196,286 F1: The shares were sold to the Issuer pursuant to a Stock Repurchase Agreement, dated August 21, 2026, between the Reporting Person (and certain trusts for the benefit of the Reporting Person's descendants) and the Issuer (the "Stock Repurchase Agreement"). Under the Stock Repurchase Agreement, the Issuer agreed to purchase an aggregate of 1,000,000 shares of common stock at a price of $34.65 per share. The Reporting Person sold 770,000 shares held directly and 230,000 shares held indirectly through trusts of which the Reporting Person is the trustee. F2: The dispositions reported herein were approved in advance by the Audit Committee of the Issuer's Board of Directors, which consists solely of two or more Non-Employee Directors (as defined in Rule 16b-3), for purposes of exempting the transactions from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(e) thereunder. F5: 30,000 shares were sold from the Robert A. Ortenzio 2014 Trust FBO Kevin M. Ortenzio at $34.65 per share for aggregate proceeds of $1,039,500. The Reporting Person is the trustee of this trust and may be deemed to have voting and investment power over the shares held therein. |
| Common StockSEC Table I · non-derivative | IndirectBy the Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio | 196,286 |
Reported balance
After 2026-08-21 transaction · row 4
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 4 · 2026-08-21 · Disposition to issuer · Disposed 30,000 · Balance 196,286 F1: The shares were sold to the Issuer pursuant to a Stock Repurchase Agreement, dated August 21, 2026, between the Reporting Person (and certain trusts for the benefit of the Reporting Person's descendants) and the Issuer (the "Stock Repurchase Agreement"). Under the Stock Repurchase Agreement, the Issuer agreed to purchase an aggregate of 1,000,000 shares of common stock at a price of $34.65 per share. The Reporting Person sold 770,000 shares held directly and 230,000 shares held indirectly through trusts of which the Reporting Person is the trustee. F2: The dispositions reported herein were approved in advance by the Audit Committee of the Issuer's Board of Directors, which consists solely of two or more Non-Employee Directors (as defined in Rule 16b-3), for purposes of exempting the transactions from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(e) thereunder. F6: 30,000 shares were sold from the Robert A. Ortenzio 2014 Trust FBO Bryan A. Ortenzio at $34.65 per share for aggregate proceeds of $1,039,500. The Reporting Person is the trustee of this trust and may be deemed to have voting and investment power over the shares held therein. |
| Common StockSEC Table I · non-derivative | IndirectBy the Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio | 206,286 |
Reported balance
After 2026-08-21 transaction · row 5
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 5 · 2026-08-21 · Disposition to issuer · Disposed 20,000 · Balance 206,286 F1: The shares were sold to the Issuer pursuant to a Stock Repurchase Agreement, dated August 21, 2026, between the Reporting Person (and certain trusts for the benefit of the Reporting Person's descendants) and the Issuer (the "Stock Repurchase Agreement"). Under the Stock Repurchase Agreement, the Issuer agreed to purchase an aggregate of 1,000,000 shares of common stock at a price of $34.65 per share. The Reporting Person sold 770,000 shares held directly and 230,000 shares held indirectly through trusts of which the Reporting Person is the trustee. F2: The dispositions reported herein were approved in advance by the Audit Committee of the Issuer's Board of Directors, which consists solely of two or more Non-Employee Directors (as defined in Rule 16b-3), for purposes of exempting the transactions from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(e) thereunder. F7: 20,000 shares were sold from the Robert A. Ortenzio 2014 Trust FBO Madeline G. Ortenzio at $34.65 per share for aggregate proceeds of $693,000. The Reporting Person is the trustee of this trust and may be deemed to have voting and investment power over the shares held therein. |
| Common StockSEC Table I · non-derivative | IndirectThe Rocco A. Ortenzio Separate Descendants Trust FBO Robert Ortenzio | 503,455 |
Reported balance
Holding disclosure · report date 2026-08-21 · row 6
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 6 · Balance 503,455 F8: These shares were inadvertently omitted from the original Form 4 filing. No change in the Reporting Person's beneficial ownership of these shares has occurred. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were sold to the Issuer pursuant to a Stock Repurchase Agreement, dated August 21, 2026, between the Reporting Person (and certain trusts for the benefit of the Reporting Person's descendants) and the Issuer (the "Stock Repurchase Agreement"). Under the Stock Repurchase Agreement, the Issuer agreed to purchase an aggregate of 1,000,000 shares of common stock at a price of $34.65 per share. The Reporting Person sold 770,000 shares held directly and 230,000 shares held indirectly through trusts of which the Reporting Person is the trustee.
F2: The dispositions reported herein were approved in advance by the Audit Committee of the Issuer's Board of Directors, which consists solely of two or more Non-Employee Directors (as defined in Rule 16b-3), for purposes of exempting the transactions from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(e) thereunder.
F3: The total number of securities reported has been updated to correct an administrative error.
F4: 150,000 shares were sold from The Robert A. Ortenzio Descendants Trust at $34.65 per share for aggregate proceeds of $5,197,500. The Reporting Person is the trustee of this trust and may be deemed to have voting and investment power over the shares held therein.
F5: 30,000 shares were sold from the Robert A. Ortenzio 2014 Trust FBO Kevin M. Ortenzio at $34.65 per share for aggregate proceeds of $1,039,500. The Reporting Person is the trustee of this trust and may be deemed to have voting and investment power over the shares held therein.
F6: 30,000 shares were sold from the Robert A. Ortenzio 2014 Trust FBO Bryan A. Ortenzio at $34.65 per share for aggregate proceeds of $1,039,500. The Reporting Person is the trustee of this trust and may be deemed to have voting and investment power over the shares held therein.
F7: 20,000 shares were sold from the Robert A. Ortenzio 2014 Trust FBO Madeline G. Ortenzio at $34.65 per share for aggregate proceeds of $693,000. The Reporting Person is the trustee of this trust and may be deemed to have voting and investment power over the shares held therein.
F8: These shares were inadvertently omitted from the original Form 4 filing. No change in the Reporting Person's beneficial ownership of these shares has occurred.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
SELECT MEDICAL HOLDINGS CORP
Report date June 30, 2026 · Filed July 01, 2026
Section 16 reporting ended · disclosed 2026-07-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-06-30 transaction · row 1
1 source rowRow 1 · 2026-06-30 · Other · Disposed 7,081,788 · Balance 0 F1: This Form 4 reports securities disposed of under the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation ("Parent"), and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026). F2: Immediately prior to the effective time of the merger, the Reporting Person contributed 6,674,010 common shares and 407,778 restricted shares to Parent in exchange for an equivalent amount of shares of common stock ("Parent Common Shares") and restricted shares, respectively, of Parent, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP. |
| Common StockSEC Table I · non-derivative | IndirectBy the Robert A. Ortenzio Descendants Trust | 0 |
Last balance in matching sequence
After 2026-06-30 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 2 · 2026-06-30 · Other · Disposed 1,000,000 · Balance 279,000 F1: This Form 4 reports securities disposed of under the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation ("Parent"), and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026). F3: Immediately prior to the effective time of the merger, The Robert A. Ortenzio Descendants Trust contributed 1,000,000 common shares ("Rollover Shares") to Parent in exchange for an equivalent amount of Parent Common Shares, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP. F4: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Row 3 · 2026-06-30 · Disposition to issuer · Disposed 279,000 · Balance 0 F1: This Form 4 reports securities disposed of under the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation ("Parent"), and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026). F5: At the effective time of the merger, each of the shares of common stock reported in this row of this Form 4 issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $16.50 per share in cash without interest. F4: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectBy the Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio | 0 |
Reported balance
After 2026-06-30 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2026-06-30 · Other · Disposed 280,415 · Balance 0 F1: This Form 4 reports securities disposed of under the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation ("Parent"), and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026). F6: Immediately prior to the effective time of the merger, The Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio contributed 280,415 common shares to Parent in exchange for an equivalent amount of Parent Common Shares, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP. F4: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectBy the Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio | 0 |
Reported balance
After 2026-06-30 transaction · row 5
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 5 · 2026-06-30 · Other · Disposed 280,415 · Balance 0 F1: This Form 4 reports securities disposed of under the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation ("Parent"), and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026). F7: Immediately prior to the effective time of the merger, The Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio contributed 280,415 common shares to Parent in exchange for an equivalent amount of Parent Common Shares, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP. F4: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectBy the Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio | 0 |
Reported balance
After 2026-06-30 transaction · row 6
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 6 · 2026-06-30 · Other · Disposed 280,415 · Balance 0 F1: This Form 4 reports securities disposed of under the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation ("Parent"), and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026). F8: Immediately prior to the effective time of the merger, The Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio contributed 280,415 common shares to Parent in exchange for an equivalent amount of Parent Common Shares, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP. F4: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 reports securities disposed of under the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation ("Parent"), and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026).
F2: Immediately prior to the effective time of the merger, the Reporting Person contributed 6,674,010 common shares and 407,778 restricted shares to Parent in exchange for an equivalent amount of shares of common stock ("Parent Common Shares") and restricted shares, respectively, of Parent, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP.
F3: Immediately prior to the effective time of the merger, The Robert A. Ortenzio Descendants Trust contributed 1,000,000 common shares ("Rollover Shares") to Parent in exchange for an equivalent amount of Parent Common Shares, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP.
F4: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F5: At the effective time of the merger, each of the shares of common stock reported in this row of this Form 4 issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $16.50 per share in cash without interest.
F6: Immediately prior to the effective time of the merger, The Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio contributed 280,415 common shares to Parent in exchange for an equivalent amount of Parent Common Shares, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP.
F7: Immediately prior to the effective time of the merger, The Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio contributed 280,415 common shares to Parent in exchange for an equivalent amount of Parent Common Shares, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP.
F8: Immediately prior to the effective time of the merger, The Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio contributed 280,415 common shares to Parent in exchange for an equivalent amount of Parent Common Shares, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 21, 2026 Filed Aug 25, 2026 21:03 UTC | Concentra Group Holdings Parent, Inc. CON · Entity 4001 | Disposition to issuerCommon Stock | 20,000 | $34.65 | $693,000.00 |
DisclosureSEC source: 0000918697-26-000011 · wk-form4_1787691817.xml · nonDerivative · entry 5 ORTENZIO ROBERT A · CIK 0000918697 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By the Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio Disclosed balance after: 206,286 F1 · kind: The shares were sold to the Issuer pursuant to a Stock Repurchase Agreement, dated August 21, 2026, between the Reporting Person (and certain trusts for the benefit of the Reporting Person's descendants) and the Issuer (the "Stock Repurchase Agreement"). Under the Stock Repurchase Agreement, the Issuer agreed to purchase an aggregate of 1,000,000 shares of common stock at a price of $34.65 per share. The Reporting Person sold 770,000 shares held directly and 230,000 shares held indirectly through trusts of which the Reporting Person is the trustee. F2 · acquired: The dispositions reported herein were approved in advance by the Audit Committee of the Issuer's Board of Directors, which consists solely of two or more Non-Employee Directors (as defined in Rule 16b-3), for purposes of exempting the transactions from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(e) thereunder. F6 · ownership.direct: 20,000 shares were sold from the Robert A. Ortenzio 2014 Trust FBO Madeline G. Ortenzio at $34.65 per share for aggregate proceeds of $693,000. The Reporting Person is the trustee of this trust and may be deemed to have voting and investment power over the shares held therein. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 21:03 UTC | Concentra Group Holdings Parent, Inc. CON · Entity 4001 | Disposition to issuerCommon Stock | 30,000 | $35.65 | $1,069,500.00 |
DisclosureSEC source: 0000918697-26-000011 · wk-form4_1787691817.xml · nonDerivative · entry 4 ORTENZIO ROBERT A · CIK 0000918697 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By the Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio Disclosed balance after: 196,286 F1 · kind: The shares were sold to the Issuer pursuant to a Stock Repurchase Agreement, dated August 21, 2026, between the Reporting Person (and certain trusts for the benefit of the Reporting Person's descendants) and the Issuer (the "Stock Repurchase Agreement"). Under the Stock Repurchase Agreement, the Issuer agreed to purchase an aggregate of 1,000,000 shares of common stock at a price of $34.65 per share. The Reporting Person sold 770,000 shares held directly and 230,000 shares held indirectly through trusts of which the Reporting Person is the trustee. F2 · acquired: The dispositions reported herein were approved in advance by the Audit Committee of the Issuer's Board of Directors, which consists solely of two or more Non-Employee Directors (as defined in Rule 16b-3), for purposes of exempting the transactions from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(e) thereunder. F5 · ownership.direct: 30,000 shares were sold from the Robert A. Ortenzio 2014 Trust FBO Bryan A. Ortenzio at $34.65 per share for aggregate proceeds of $1,039,500. The Reporting Person is the trustee of this trust and may be deemed to have voting and investment power over the shares held therein. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 21:03 UTC | Concentra Group Holdings Parent, Inc. CON · Entity 4001 | Disposition to issuerCommon Stock | 30,000 | $34.65 | $1,039,500.00 |
DisclosureSEC source: 0000918697-26-000011 · wk-form4_1787691817.xml · nonDerivative · entry 3 ORTENZIO ROBERT A · CIK 0000918697 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By the Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio Disclosed balance after: 196,286 F1 · kind: The shares were sold to the Issuer pursuant to a Stock Repurchase Agreement, dated August 21, 2026, between the Reporting Person (and certain trusts for the benefit of the Reporting Person's descendants) and the Issuer (the "Stock Repurchase Agreement"). Under the Stock Repurchase Agreement, the Issuer agreed to purchase an aggregate of 1,000,000 shares of common stock at a price of $34.65 per share. The Reporting Person sold 770,000 shares held directly and 230,000 shares held indirectly through trusts of which the Reporting Person is the trustee. F2 · acquired: The dispositions reported herein were approved in advance by the Audit Committee of the Issuer's Board of Directors, which consists solely of two or more Non-Employee Directors (as defined in Rule 16b-3), for purposes of exempting the transactions from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(e) thereunder. F4 · ownership.direct: 30,000 shares were sold from the Robert A. Ortenzio 2014 Trust FBO Kevin M. Ortenzio at $34.65 per share for aggregate proceeds of $1,039,500. The Reporting Person is the trustee of this trust and may be deemed to have voting and investment power over the shares held therein. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 21:03 UTC | Concentra Group Holdings Parent, Inc. CON · Entity 4001 | Disposition to issuerCommon Stock | 150,000 | $34.65 | $5,197,500.00 |
DisclosureSEC source: 0000918697-26-000011 · wk-form4_1787691817.xml · nonDerivative · entry 2 ORTENZIO ROBERT A · CIK 0000918697 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By the Robert A. Ortenzio Descendants Trust Disclosed balance after: 882,115 F1 · kind: The shares were sold to the Issuer pursuant to a Stock Repurchase Agreement, dated August 21, 2026, between the Reporting Person (and certain trusts for the benefit of the Reporting Person's descendants) and the Issuer (the "Stock Repurchase Agreement"). Under the Stock Repurchase Agreement, the Issuer agreed to purchase an aggregate of 1,000,000 shares of common stock at a price of $34.65 per share. The Reporting Person sold 770,000 shares held directly and 230,000 shares held indirectly through trusts of which the Reporting Person is the trustee. F2 · acquired: The dispositions reported herein were approved in advance by the Audit Committee of the Issuer's Board of Directors, which consists solely of two or more Non-Employee Directors (as defined in Rule 16b-3), for purposes of exempting the transactions from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(e) thereunder. F3 · ownership.direct: 150,000 shares were sold from The Robert A. Ortenzio Descendants Trust at $34.65 per share for aggregate proceeds of $5,197,500. The Reporting Person is the trustee of this trust and may be deemed to have voting and investment power over the shares held therein. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 21:03 UTC | Concentra Group Holdings Parent, Inc. CON · Entity 4001 | Disposition to issuerCommon Stock | 770,000 | $34.65 | $26,680,500.00 |
DisclosureSEC source: 0000918697-26-000011 · wk-form4_1787691817.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,763,794 F1 · kind: The shares were sold to the Issuer pursuant to a Stock Repurchase Agreement, dated August 21, 2026, between the Reporting Person (and certain trusts for the benefit of the Reporting Person's descendants) and the Issuer (the "Stock Repurchase Agreement"). Under the Stock Repurchase Agreement, the Issuer agreed to purchase an aggregate of 1,000,000 shares of common stock at a price of $34.65 per share. The Reporting Person sold 770,000 shares held directly and 230,000 shares held indirectly through trusts of which the Reporting Person is the trustee. F2 · acquired: The dispositions reported herein were approved in advance by the Audit Committee of the Issuer's Board of Directors, which consists solely of two or more Non-Employee Directors (as defined in Rule 16b-3), for purposes of exempting the transactions from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(e) thereunder. Read SEC document |
| August 21, 2026 Filed Sep 1, 2026 20:10 UTC Amendment | Concentra Group Holdings Parent, Inc. CON · Entity 4001 | Disposition to issuerCommon Stock | 20,000 | $34.65 | $693,000.00 |
DisclosureSEC source: 0000918697-26-000013 · wk-form4a_1788293414.xml · nonDerivative · entry 5 ORTENZIO ROBERT A · CIK 0000918697 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By the Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio Disclosed balance after: 206,286 F1 · kind: The shares were sold to the Issuer pursuant to a Stock Repurchase Agreement, dated August 21, 2026, between the Reporting Person (and certain trusts for the benefit of the Reporting Person's descendants) and the Issuer (the "Stock Repurchase Agreement"). Under the Stock Repurchase Agreement, the Issuer agreed to purchase an aggregate of 1,000,000 shares of common stock at a price of $34.65 per share. The Reporting Person sold 770,000 shares held directly and 230,000 shares held indirectly through trusts of which the Reporting Person is the trustee. F2 · acquired: The dispositions reported herein were approved in advance by the Audit Committee of the Issuer's Board of Directors, which consists solely of two or more Non-Employee Directors (as defined in Rule 16b-3), for purposes of exempting the transactions from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(e) thereunder. F7 · ownership.direct: 20,000 shares were sold from the Robert A. Ortenzio 2014 Trust FBO Madeline G. Ortenzio at $34.65 per share for aggregate proceeds of $693,000. The Reporting Person is the trustee of this trust and may be deemed to have voting and investment power over the shares held therein. Read SEC document |
| August 21, 2026 Filed Sep 1, 2026 20:10 UTC Amendment | Concentra Group Holdings Parent, Inc. CON · Entity 4001 | Disposition to issuerCommon Stock | 30,000 | $34.65 | $1,039,500.00 |
DisclosureSEC source: 0000918697-26-000013 · wk-form4a_1788293414.xml · nonDerivative · entry 4 ORTENZIO ROBERT A · CIK 0000918697 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By the Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio Disclosed balance after: 196,286 F1 · kind: The shares were sold to the Issuer pursuant to a Stock Repurchase Agreement, dated August 21, 2026, between the Reporting Person (and certain trusts for the benefit of the Reporting Person's descendants) and the Issuer (the "Stock Repurchase Agreement"). Under the Stock Repurchase Agreement, the Issuer agreed to purchase an aggregate of 1,000,000 shares of common stock at a price of $34.65 per share. The Reporting Person sold 770,000 shares held directly and 230,000 shares held indirectly through trusts of which the Reporting Person is the trustee. F2 · acquired: The dispositions reported herein were approved in advance by the Audit Committee of the Issuer's Board of Directors, which consists solely of two or more Non-Employee Directors (as defined in Rule 16b-3), for purposes of exempting the transactions from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(e) thereunder. F6 · ownership.direct: 30,000 shares were sold from the Robert A. Ortenzio 2014 Trust FBO Bryan A. Ortenzio at $34.65 per share for aggregate proceeds of $1,039,500. The Reporting Person is the trustee of this trust and may be deemed to have voting and investment power over the shares held therein. Read SEC document |
| August 21, 2026 Filed Sep 1, 2026 20:10 UTC Amendment | Concentra Group Holdings Parent, Inc. CON · Entity 4001 | Disposition to issuerCommon Stock | 30,000 | $34.65 | $1,039,500.00 |
DisclosureSEC source: 0000918697-26-000013 · wk-form4a_1788293414.xml · nonDerivative · entry 3 ORTENZIO ROBERT A · CIK 0000918697 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By the Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio Disclosed balance after: 196,286 F1 · kind: The shares were sold to the Issuer pursuant to a Stock Repurchase Agreement, dated August 21, 2026, between the Reporting Person (and certain trusts for the benefit of the Reporting Person's descendants) and the Issuer (the "Stock Repurchase Agreement"). Under the Stock Repurchase Agreement, the Issuer agreed to purchase an aggregate of 1,000,000 shares of common stock at a price of $34.65 per share. The Reporting Person sold 770,000 shares held directly and 230,000 shares held indirectly through trusts of which the Reporting Person is the trustee. F2 · acquired: The dispositions reported herein were approved in advance by the Audit Committee of the Issuer's Board of Directors, which consists solely of two or more Non-Employee Directors (as defined in Rule 16b-3), for purposes of exempting the transactions from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(e) thereunder. F5 · ownership.direct: 30,000 shares were sold from the Robert A. Ortenzio 2014 Trust FBO Kevin M. Ortenzio at $34.65 per share for aggregate proceeds of $1,039,500. The Reporting Person is the trustee of this trust and may be deemed to have voting and investment power over the shares held therein. Read SEC document |
| August 21, 2026 Filed Sep 1, 2026 20:10 UTC Amendment | Concentra Group Holdings Parent, Inc. CON · Entity 4001 | Disposition to issuerCommon Stock | 150,000 | $34.65 | $5,197,500.00 |
DisclosureSEC source: 0000918697-26-000013 · wk-form4a_1788293414.xml · nonDerivative · entry 2 ORTENZIO ROBERT A · CIK 0000918697 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By the Robert A. Ortenzio Descendants Trust Disclosed balance after: 882,115 F1 · kind: The shares were sold to the Issuer pursuant to a Stock Repurchase Agreement, dated August 21, 2026, between the Reporting Person (and certain trusts for the benefit of the Reporting Person's descendants) and the Issuer (the "Stock Repurchase Agreement"). Under the Stock Repurchase Agreement, the Issuer agreed to purchase an aggregate of 1,000,000 shares of common stock at a price of $34.65 per share. The Reporting Person sold 770,000 shares held directly and 230,000 shares held indirectly through trusts of which the Reporting Person is the trustee. F2 · acquired: The dispositions reported herein were approved in advance by the Audit Committee of the Issuer's Board of Directors, which consists solely of two or more Non-Employee Directors (as defined in Rule 16b-3), for purposes of exempting the transactions from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(e) thereunder. F4 · ownership.direct: 150,000 shares were sold from The Robert A. Ortenzio Descendants Trust at $34.65 per share for aggregate proceeds of $5,197,500. The Reporting Person is the trustee of this trust and may be deemed to have voting and investment power over the shares held therein. Read SEC document |
| August 21, 2026 Filed Sep 1, 2026 20:10 UTC Amendment | Concentra Group Holdings Parent, Inc. CON · Entity 4001 | Disposition to issuerCommon Stock | 770,000 | $34.65 | $26,680,500.00 |
DisclosureSEC source: 0000918697-26-000013 · wk-form4a_1788293414.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,663,794 F1 · kind: The shares were sold to the Issuer pursuant to a Stock Repurchase Agreement, dated August 21, 2026, between the Reporting Person (and certain trusts for the benefit of the Reporting Person's descendants) and the Issuer (the "Stock Repurchase Agreement"). Under the Stock Repurchase Agreement, the Issuer agreed to purchase an aggregate of 1,000,000 shares of common stock at a price of $34.65 per share. The Reporting Person sold 770,000 shares held directly and 230,000 shares held indirectly through trusts of which the Reporting Person is the trustee. F2 · acquired: The dispositions reported herein were approved in advance by the Audit Committee of the Issuer's Board of Directors, which consists solely of two or more Non-Employee Directors (as defined in Rule 16b-3), for purposes of exempting the transactions from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(e) thereunder. F3 · balance_after: The total number of securities reported has been updated to correct an administrative error. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:31 UTC | Concentra Group Holdings Parent, Inc. CON · Entity 4001 | SaleCommon Stock | 130,000 | $31.84 | $4,139,356.00 |
DisclosureSEC source: 0000918697-26-000009 · wk-form4_1785961883.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director 10b5-1 filing: Plan reported Ownership: Indirect · The Rocco A. Ortenzio Separate Descendants Trust FBO Robert Ortenzio Disclosed balance after: 503,455 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.65 to $32.035, inclusive. The reporting person undertakes to provide to Concentra Group Holdings Parent, Inc., any security holder of Concentra Group Holdings Parent, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 20:05 UTC | Concentra Group Holdings Parent, Inc. CON · Entity 4001 | SaleCommon Stock | 130,000 | $30.50 | $3,964,597.00 |
DisclosureSEC source: 0000918697-26-000007 · wk-form4_1783368347.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director 10b5-1 filing: Plan reported Ownership: Indirect · The Rocco A. Ortenzio Separate Descendants Trust FBO Robert Ortenzio Disclosed balance after: 633,455 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.45 to $30.85, inclusive. The reporting person undertakes to provide to Concentra Group Holdings Parent, Inc., any security holder of Concentra Group Holdings Parent, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 18:15 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | OtherCommon Stock | 280,415 | $0.00 | $0.00 |
DisclosureSEC source: 0000918697-26-000005 · form4-07012026_060724.xml · nonDerivative · entry 6 ORTENZIO ROBERT A · CIK 0000918697 · Director · EXECUTIVE CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By the Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio Disclosed balance after: 0 F1 · kind: This Form 4 reports securities disposed of under the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation ("Parent"), and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026). F8 · shares: Immediately prior to the effective time of the merger, The Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio contributed 280,415 common shares to Parent in exchange for an equivalent amount of Parent Common Shares, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP. F4 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 18:15 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | OtherCommon Stock | 280,415 | $0.00 | $0.00 |
DisclosureSEC source: 0000918697-26-000005 · form4-07012026_060724.xml · nonDerivative · entry 5 ORTENZIO ROBERT A · CIK 0000918697 · Director · EXECUTIVE CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By the Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio Disclosed balance after: 0 F1 · kind: This Form 4 reports securities disposed of under the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation ("Parent"), and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026). F7 · shares: Immediately prior to the effective time of the merger, The Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio contributed 280,415 common shares to Parent in exchange for an equivalent amount of Parent Common Shares, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP. F4 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 18:15 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | OtherCommon Stock | 280,415 | $0.00 | $0.00 |
DisclosureSEC source: 0000918697-26-000005 · form4-07012026_060724.xml · nonDerivative · entry 4 ORTENZIO ROBERT A · CIK 0000918697 · Director · EXECUTIVE CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By the Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio Disclosed balance after: 0 F1 · kind: This Form 4 reports securities disposed of under the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation ("Parent"), and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026). F6 · shares: Immediately prior to the effective time of the merger, The Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio contributed 280,415 common shares to Parent in exchange for an equivalent amount of Parent Common Shares, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP. F4 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 18:15 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | Disposition to issuerCommon Stock | 279,000 | $16.50 | $4,603,500.00 |
DisclosureSEC source: 0000918697-26-000005 · form4-07012026_060724.xml · nonDerivative · entry 3 ORTENZIO ROBERT A · CIK 0000918697 · Director · EXECUTIVE CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By the Robert A. Ortenzio Descendants Trust Disclosed balance after: 0 F1 · kind: This Form 4 reports securities disposed of under the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation ("Parent"), and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026). F5 · shares: At the effective time of the merger, each of the shares of common stock reported in this row of this Form 4 issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $16.50 per share in cash without interest. F4 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 18:15 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | OtherCommon Stock | 1,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000918697-26-000005 · form4-07012026_060724.xml · nonDerivative · entry 2 ORTENZIO ROBERT A · CIK 0000918697 · Director · EXECUTIVE CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By the Robert A. Ortenzio Descendants Trust Disclosed balance after: 279,000 F1 · kind: This Form 4 reports securities disposed of under the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation ("Parent"), and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026). F3 · shares: Immediately prior to the effective time of the merger, The Robert A. Ortenzio Descendants Trust contributed 1,000,000 common shares ("Rollover Shares") to Parent in exchange for an equivalent amount of Parent Common Shares, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP. F4 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 18:15 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | OtherCommon Stock | 7,081,788 | $0.00 | $0.00 |
DisclosureSEC source: 0000918697-26-000005 · form4-07012026_060724.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · EXECUTIVE CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: This Form 4 reports securities disposed of under the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation ("Parent"), and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026). F2 · shares: Immediately prior to the effective time of the merger, the Reporting Person contributed 6,674,010 common shares and 407,778 restricted shares to Parent in exchange for an equivalent amount of shares of common stock ("Parent Common Shares") and restricted shares, respectively, of Parent, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP. Read SEC document |
| June 01, 2026 Filed Jun 2, 2026 20:29 UTC | Concentra Group Holdings Parent, Inc. CON · Entity 4001 | SaleCommon Stock | 130,000 | $25.00 | $3,250,026.00 |
DisclosureSEC source: 0000918697-26-000004 · wk-form4_1780432188.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director 10b5-1 filing: Plan reported Ownership: Indirect · The Rocco A. Ortenzio Separate Descendants Trust FBO Robert Ortenzio Disclosed balance after: 763,455 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.03, inclusive. The reporting person undertakes to provide to Concentra Group Holdings Parent, Inc., any security holder of Concentra Group Holdings Parent, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| May 08, 2026 Filed May 11, 2026 21:01 UTC | Concentra Group Holdings Parent, Inc. CON · Entity 4001 | SaleCommon Stock | 130,000 | $25.00 | $3,250,000.00 |
DisclosureSEC source: 0000918697-26-000002 · wk-form4_1778533282.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director 10b5-1 filing: Plan reported Ownership: Indirect · The Rocco A. Ortenzio Separate Descendants Trust FBO Robert Ortenzio Disclosed balance after: 893,455 Read SEC document |
| November 25, 2025 Filed Nov 26, 2025 23:00 UTC | Concentra Group Holdings Parent, Inc. CON · Entity 4001 | GiftCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-116512 · tm2532328-1_4seq1.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,433,794 F1 · kind: Represents a bona fide gift by the reporting person. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 22:25 UTC | Concentra Group Holdings Parent, Inc. CON · Entity 4001 | GrantCommon Stock | 7,748 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-107884 · tm2530505-17_4seq1.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,533,794 F1 · kind: Grant of restricted stock which, subject to certain exceptions, will vest in full on November 4, 2026, the first anniversary of the grant date. Read SEC document |
| July 29, 2025 Filed Jul 31, 2025 21:04 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-020753 · form4-07312025_090738.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,081,788 F1 · kind: Grant of restricted stock which will vest in equal annual installments over three years. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 21:59 UTC | Concentra Group Holdings Parent, Inc. CON · Entity 4001 | OtherCommon Stock | 1,023,455 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-006577 · form4-03042025_090318.xml · nonDerivative · entry 2 ORTENZIO ROBERT A · CIK 0000918697 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · The Rocco A. Ortenzio Separate Descendants Trust FBO Robert Ortenzio Disclosed balance after: 1,023,455 F2 · kind: The reporting person received 1,023,455 shares of Company's common stock from the Rocco A. Ortenzio Separate Exempt Descendants Trust. The shares are held by the Rocco A. Ortenzio Separate Descendants Trust FBO Robert A. Ortenzio. There was no consideration paid for such distribution. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 21:59 UTC | Concentra Group Holdings Parent, Inc. CON · Entity 4001 | OtherCommon Stock | 3,070,367 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-006577 · form4-03042025_090318.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By the Rocco A. Ortenzio Separate Exempt Descendants Trust Disclosed balance after: 0 F1 · kind: The Rocco A. Ortenzio Separate Exempt Descendants Trust transferred in the aggregate 3,070,367 shares of Company's common stock to the Rocco A. Ortenzio Separate Descendants FBO Robert Ortenzio, the Rocco A. Ortenzio Separate Descendants FBO John Ortenzio and the Rocco A. Ortenzio Separate Descendants FBO Martin Ortenzio. There was no consideration paid for such distribution. Read SEC document |
| November 26, 2024 Filed Nov 29, 2024 23:55 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 3,804,805 | $19.55 | $74,383,937.75 |
DisclosureSEC source: 0001415889-24-027954 · form4-11292024_111149.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Indirect · By the Rocco A. Ortenzio Separate Exempt Descendants Trust Disclosed balance after: 0 F1 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| November 26, 2024 Filed Nov 29, 2024 22:26 UTC | Concentra Group Holdings Parent, Inc. CON · Entity 4001 | GrantCommon Stock | 6,496 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-027932 · form4-11292024_101146.xml · nonDerivative · entry 2 ORTENZIO ROBERT A · CIK 0000918697 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,526,046 F2 · kind: Grant of restricted stock which, subject to certain exceptions, will vest in full on November 26, 2025, the first anniversary of the grant date Read SEC document |
| November 26, 2024 Filed Nov 29, 2024 22:26 UTC | Concentra Group Holdings Parent, Inc. CON · Entity 4001 | GrantCommon Stock | 6,496 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-027932 · form4-11292024_101146.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,519,550 F1 · kind: Grant of restricted stock which will vest in equal annual installments over five years. Read SEC document |
| November 25, 2024 Filed Nov 25, 2024 22:19 UTC | Concentra Group Holdings Parent, Inc. CON · Entity 4001 | OtherCommon Stock | 226,286 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-027652 · form4-11252024_101146.xml · nonDerivative · entry 6 ORTENZIO ROBERT A · CIK 0000918697 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By the Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio Disclosed balance after: 226,286 F1 · kind: The transactions reported herein are the result of the consummation on November 25, 2024 of the distribution of all the shares of common stock of Concentra Group Holdings Parent, Inc. by Select Medical Holdings Corporation ("Select") to holders of Select common stock on a pro rata basis. These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F2 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| November 25, 2024 Filed Nov 25, 2024 22:19 UTC | Concentra Group Holdings Parent, Inc. CON · Entity 4001 | OtherCommon Stock | 226,286 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-027652 · form4-11252024_101146.xml · nonDerivative · entry 5 ORTENZIO ROBERT A · CIK 0000918697 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By the Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio Disclosed balance after: 226,286 F1 · kind: The transactions reported herein are the result of the consummation on November 25, 2024 of the distribution of all the shares of common stock of Concentra Group Holdings Parent, Inc. by Select Medical Holdings Corporation ("Select") to holders of Select common stock on a pro rata basis. These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F2 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| November 25, 2024 Filed Nov 25, 2024 22:19 UTC | Concentra Group Holdings Parent, Inc. CON · Entity 4001 | OtherCommon Stock | 226,286 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-027652 · form4-11252024_101146.xml · nonDerivative · entry 4 ORTENZIO ROBERT A · CIK 0000918697 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By the Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio Disclosed balance after: 226,286 F1 · kind: The transactions reported herein are the result of the consummation on November 25, 2024 of the distribution of all the shares of common stock of Concentra Group Holdings Parent, Inc. by Select Medical Holdings Corporation ("Select") to holders of Select common stock on a pro rata basis. These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F2 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| November 25, 2024 Filed Nov 25, 2024 22:19 UTC | Concentra Group Holdings Parent, Inc. CON · Entity 4001 | OtherCommon Stock | 3,070,367 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-027652 · form4-11252024_101146.xml · nonDerivative · entry 3 ORTENZIO ROBERT A · CIK 0000918697 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By the Rocco A. Ortenzio Separate Exempt Descendants Trust Disclosed balance after: 3,070,367 F1 · kind: The transactions reported herein are the result of the consummation on November 25, 2024 of the distribution of all the shares of common stock of Concentra Group Holdings Parent, Inc. by Select Medical Holdings Corporation ("Select") to holders of Select common stock on a pro rata basis. These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F2 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| November 25, 2024 Filed Nov 25, 2024 22:19 UTC | Concentra Group Holdings Parent, Inc. CON · Entity 4001 | OtherCommon Stock | 1,032,115 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-027652 · form4-11252024_101146.xml · nonDerivative · entry 2 ORTENZIO ROBERT A · CIK 0000918697 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By the Robert A. Ortenzio Descendants Trust Disclosed balance after: 1,032,115 F1 · kind: The transactions reported herein are the result of the consummation on November 25, 2024 of the distribution of all the shares of common stock of Concentra Group Holdings Parent, Inc. by Select Medical Holdings Corporation ("Select") to holders of Select common stock on a pro rata basis. These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F2 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| November 25, 2024 Filed Nov 25, 2024 22:19 UTC | Concentra Group Holdings Parent, Inc. CON · Entity 4001 | OtherCommon Stock | 5,513,054 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-027652 · form4-11252024_101146.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,513,054 F1 · kind: The transactions reported herein are the result of the consummation on November 25, 2024 of the distribution of all the shares of common stock of Concentra Group Holdings Parent, Inc. by Select Medical Holdings Corporation ("Select") to holders of Select common stock on a pro rata basis. These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. Read SEC document |
| August 03, 2024 Filed Aug 5, 2024 20:34 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | Tax withholdingCommon Stock | 87,880 | $34.18 | $3,003,738.40 |
DisclosureSEC source: 0001415889-24-020753 · form4-08052024_080815.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,831,788 F1 · kind: Surrender of shares to satisfy tax withholding obligation incident to vesting of restricted stock. Read SEC document |
| April 30, 2024 Filed May 1, 2024 23:43 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 230,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-011926 · form4-05012024_110554.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,919,668 F1 · kind: Grant of restricted stock which will vest in equal annual installments over three years Read SEC document |
| April 08, 2024 Filed Apr 10, 2024 20:44 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 50,000 | $29.90 | $1,495,000.00 |
DisclosureSEC source: 0001415889-24-010655 · form4-04102024_080427.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,689,668 F1 · kind: These shares were sold pursuant to a 10b5-1 trading plan adopted by Robert A. Ortenzio on December 9, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.72 to $30.20, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:43 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 50,000 | $28.30 | $1,415,000.00 |
DisclosureSEC source: 0001415889-24-007517 · form4-03112024_080324.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,739,668 F1 · kind: These shares were sold pursuant to a 10b5-1 trading plan adopted by Robert A. Ortenzio on December 9, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.08 to $28.595, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Read SEC document |
| February 08, 2024 Filed Feb 9, 2024 21:34 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 50,000 | $26.00 | $1,300,000.00 |
DisclosureSEC source: 0001415889-24-003184 · form4-02092024_090254.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,789,668 F1 · kind: These shares were sold pursuant to a 10b5-1 trading plan adopted by Robert A. Ortenzio on December 9, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.685 to $26.31, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Read SEC document |
| January 08, 2024 Filed Jan 9, 2024 21:42 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 100,000 | $26.63 | $2,663,000.00 |
DisclosureSEC source: 0001415889-24-000855 · form4-01092024_090101.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,839,668 F1 · kind: These shares were sold pursuant to a 10b5-1 trading plan adopted by Robert A. Ortenzio on December 9, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.28 to $27.015, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Read SEC document |
| December 14, 2023 Filed Dec 14, 2023 21:57 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 100,000 | $25.00 | $2,500,000.00 |
DisclosureSEC source: 0001415889-23-016490 · form4-12142023_091215.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,939,668 F1 · kind: These shares were sold pursuant to a 10b5-1 trading plan adopted by Robert A. Ortenzio on December 9, 2022. Read SEC document |
| September 08, 2023 Filed Sep 11, 2023 20:01 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 50,000 | $26.82 | $1,341,000.00 |
DisclosureSEC source: 0001415889-23-013143 · form4-09112023_080918.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,039,668 F1 · kind: These shares were sold pursuant to a 10b5-1 trading plan adopted by Robert A. Ortenzio on December 9, 2022 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.70 to $27.22, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Read SEC document |
| August 08, 2023 Filed Aug 9, 2023 21:40 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 50,000 | $29.52 | $1,476,000.00 |
DisclosureSEC source: 0001415889-23-011985 · form4-08092023_090849.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,089,668 F1 · kind: These shares were sold pursuant to a 10b5-1 trading plan adopted by Robert A. Ortenzio on December 9, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.355 to $30.035, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Read SEC document |
| August 01, 2023 Filed Aug 2, 2023 20:28 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-011747 · form4-08022023_080823.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,139,668 F1 · kind: Grant of restricted stock which will vest in equal annual installments over three years. Read SEC document |
| July 10, 2023 Filed Jul 11, 2023 22:43 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 50,000 | $30.36 | $1,518,000.00 |
DisclosureSEC source: 0001415889-23-011033 · form4-07112023_100704.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,889,668 F1 · kind: These shares were sold pursuant to a 10b5-1 trading plan adopted by Robert A. Ortenzio on December 9, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.48 to $30.585, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote Read SEC document |
| June 29, 2023 Filed Jun 30, 2023 21:27 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 100,000 | $32.00 | $3,200,000.00 |
DisclosureSEC source: 0001415889-23-010489 · form4-06302023_090607.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: Plan reported Ownership: Indirect · By the Robert A. Ortenzio Descendants Trust Disclosed balance after: 1,279,000 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Robert A. Ortenzio Descendants Trust on December 9, 2022. F2 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| June 21, 2023 Filed Jun 22, 2023 22:00 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 33,967 | $30.00 | $1,019,010.00 |
DisclosureSEC source: 0001415889-23-010169 · form4-06222023_060601.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: Plan reported Ownership: Indirect · By the Robert A. Ortenzio Descendants Trust Disclosed balance after: 1,379,000 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Robert A. Ortenzio Descendants Trust on December 9, 2022. F2 · ownership.nature: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| June 08, 2023 Filed Jun 9, 2023 21:13 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 50,000 | $28.63 | $1,431,500.00 |
DisclosureSEC source: 0001415889-23-009516 · form4-06092023_090658.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,939,668 F1 · kind: These shares were sold pursuant to a 10b5-1 trading plan adopted by Robert A. Ortenzio on December 9, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.28 to $29.07, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Read SEC document |
| May 08, 2023 Filed May 9, 2023 22:28 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 116,033 | $29.80 | $3,457,783.40 |
DisclosureSEC source: 0001415889-23-007696 · form4-05092023_100544.xml · nonDerivative · entry 2 ORTENZIO ROBERT A · CIK 0000918697 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: Plan reported Ownership: Indirect · By the Robert A. Ortenzio Descendants Trust Disclosed balance after: 1,412,967 F3 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Robert A. Ortenzio Descendants Trust on December 9, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.285 to $30.65, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Read SEC document |
| May 08, 2023 Filed May 9, 2023 22:28 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | SaleCommon Stock | 50,000 | $29.68 | $1,484,000.00 |
DisclosureSEC source: 0001415889-23-007696 · form4-05092023_100544.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,989,668 F1 · kind: These shares were sold pursuant to a 10b5-1 trading plan adopted by Robert A. Ortenzio on December 9, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.295 to $30.65, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.